Katharina Wartha

Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy

Carola H. Ries, Michael A. Cannarile, Sabine Hoves et al. · Cancer Cell · 2014 · 1.3K citations

Cancer Therapy, Tumor Biology, Tumor-associated Macrophages +12

Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity

Sabine Hoves, Chia-Huey Ooi, Carsten Wolter et al. · The Journal of Experimental Medicine · 2018 · 205 citations · Full text

Rapid Activation, Immune Evasion, Cancer Immunosurveillance +14

RG7386, a Novel Tetravalent FAP-DR5 Antibody, Effectively Triggers FAP-Dependent, Avidity-Driven DR5 Hyperclustering and Tumor Cell Apoptosis

Peter Brünker, Katharina Wartha, Thomas Friess et al. · Molecular Cancer Therapeutics · 2016 · 131 citations · Full text

A Novel Glycoengineered Bispecific Antibody Format for Targeted Inhibition of Epidermal Growth Factor Receptor (EGFR) and Insulin-like Growth Factor Receptor Type I (IGF-1R) Demonstrating Unique Molecular Properties

Juergen Schanzer, Katharina Wartha, Rebecca Croasdale et al. · Journal of Biological Chemistry · 2014 · 57 citations · Full text

Human Growth, Targeted Inhibition, Glycobiology +9

Development of tetravalent IgG1 dual targeting IGF-1R–EGFR antibodies with potent tumor inhibition

Rebecca Croasdale, Katharina Wartha, Juergen Schanzer et al. · Archives of Biochemistry and Biophysics · 2012 · 45 citations

Igf-1r–egfr Antibodies, Medicine, Immunology +11